OOIR: Observatory of International Research

Papers

(The H4-Index of Haematologica is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Bence Jones Island in Shepherd Bay, Nunavut: a little known tribute to the legendary physician and chemist’s “thé de voyage”	193
Epigenetic dysregulation of eukaryotic initiation factor 3 subunit E (eIF3E) by lysine methyltransferase REIIBP confers a pro-inflammatory phenotype in t(4;14) myeloma	128
Genome-wide assessment of genetic risk loci for childhood acute lymphoblastic leukemia in Japanese patients	119
Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation	82
BCL2 inhibition in adult acute lymphoblastic leukemia: ready for primetime?	72
The first human acute myeloid leukemia genome ever fully sequenced	72
Intra-marrow delivery of human interleukin-6-loaded biodegradable microspheres promotes growth of patient-derived multiple myeloma cells in mice	70
Impact of soluble thrombomodulin and activated protein C on dynamic hemostatic function in trauma: a focus on thrombin generation and clot lysis	69
Genetic risk classification in acute myeloid leukemia patients treated with hematopoietic cell transplantation and post-transplant cyclophosphamide	68
Asparaginase-associated hyperammonemia	66
Asciminib in chronic myeloid leukemia: a STAMP for expedited delivery?	65
The polymerase chain reaction, so simple, so clever: the discovery that made minimal residual disease come true	61
Acute myeloid leukemia at first relapse: approaching the precipice	59
Hematopoietic cell transplantation soon after first relapse in acute myeloid leukemia – the CONS	58
Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection	56
Old methods, lasting impact in relapsed/refractory primary mediastinal B-cell lymphoma	50
Asparaginase dosing for acute lymphoblastic leukemia: more questions than answers	49
Comprehensive characterization of human bone marrow microenvironment shows age-related changes	49
PHF6 interacts with the LMO2 complex in T-cell acute lymphoblastic leukemia	49
Next generation sequencing panel for hereditary erythrocytosis in adults with otherwise unexplained erythrocytosis unveils additional genomic variants	48
Relapsed classic Hodgkin lymphoma; should all patients receive an autologous stem cell transplant? – the PRO	48
JAK inhibitor selection in challenging scenarios of myelofibrosis: a review	48
Soluble SLAMF7 is generated by alternative splicing in multiple myeloma cells	47
Genetic testing guides therapy in children with refractory cytopenias	46
Clonal hematopoiesis by DNMT3A mutations as a common finding in idiopathic splanchnic vein thrombosis	46

Investigating the influence of germline <i>ATM</i> variants in chronic lymphocytic leukemia on cancer vulnerability	44
CD47 expression in acute myeloid leukemia varies according to genotype	44
LILRB4 represents a promising target for immunotherapy by dual targeting tumor cells and myeloid-derived suppressive cells in multiple myeloma	42
Potassium/sodium cation carriers robustly up-regulate CD20 antigen by targeting MYC, and synergize with anti-CD20 immunotherapies to eliminate malignant B cells	41
Clinical impact of clonal hematopoiesis in hematopoietic cell transplantation: a review, metaanalysis, and call to action	40
Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphoma	40
The patient voice: measuring what matters in lower-risk myelodysplastic syndromes treated with imetelstat	38
The dilemma after chimeric antigen receptor T-cell therapy – to transplant or not?	37
Scott syndrome with novel compound heterozygous pathogenic variants in <i>ANO6</i> and reduced thrombin generation	36
Artificial intelligence-based quantitative bone marrow pathology analysis for myeloproliferative neoplasms	34
Mutational and copy number analysis at diagnosis and relapse of mantle cell lymphoma	34
CO05 \| Identification of <i>wnk1</i> as a druggable target in <i>TAL1</i>-related T-cell acute lymphoblastic leukemia	34
CO42 \| Dynamic changes after allogeneic stem cell transplantation of extracellular vesicles originated from platelets, endothelial cells and leukocytes after: correlation with acute graft-versus-host	34